348
Participants
Start Date
October 14, 2020
Primary Completion Date
June 30, 2028
Study Completion Date
July 31, 2028
U101
One capsule (100 mg) of U101 will be administered orally three times per day (TID) for 8 weeks followed by one capsule of U101 twice per day (BID) for 16 weeks.
Placebo
One capsule of Placebo will be administered orally three times per day (TID) for 8 weeks followed by one capsule of placebo twice per day (BID) for 16 weeks.
RECRUITING
Chang Gung Memorial Hospital, Kaohsiung Branch, Kaohsiung City
ACTIVE_NOT_RECRUITING
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
RECRUITING
Taipei Tzu Chi Hospital, New Taipei City
RECRUITING
China Medical University Hospital, Taichung
RECRUITING
Chung Shan Medical University Hospital, Taichung
RECRUITING
Taichung Veterans General Hospital, Taichung
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Chang Gung Memorial Hospital, Taipei Branch, Taipei
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Taipei Medical University Hospital, Taipei
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
Tri-Service General Hospital (TSGH), Taipei
RECRUITING
Chang Gung Memorial Hospital, Linkuo Branch, Taoyuan District
TCM Biotech International Corp.
INDUSTRY